Favipiravir Intermediates are launched in June 2020, and commercially provided at tons.
6-Bromo-3-hydroxypyrazine-2-carboxamide, CAS No.: 259793-88-9
3-Hydroxypyrazine-2-carboxamide, CAS No.: 55321-99-8
2-aminopropanediamide, CAS No.: 62009-47-6
Diethyl 2-aminopropanedioate hydrochloride, CAS No.: 13433-00-6